Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Poli

Showing results (181-190 of 212) with videos related to

Pageof 22
Sort By:
Neurological Research and Practice|June 26, 2025
Baseline characteristics of patients with acute ischaemic stroke included in the randomised controlled Find-AF 2 trialKatrin Wasser, Tobias Uhe, Wolf-Rüdiger Schäbitz, et al.
European Stroke Journal|April 4, 2024
Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19Adrian Scutelnic, Anita van de Munckhof, Angel T Miraclin, et al.
European Stroke Journal|September 29, 2023
Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopeniaJohannes Weller, Katarzyna Krzywicka, Anita van de Munckhof, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 18, 2024
Reducing the global burden of cerebral venous thrombosis: An international research agendaJonathan M Coutinho, Anita van de Munckhof, Diana Aguiar de Sousa, et al.
Science Translational Medicine|January 14, 2026
Brain-derived tau for monitoring brain injury in acute ischemic strokeNaomi Vlegels, Nicoló L Knuth, Konstantin A Steiner, et al.
Lancet (London, England)|February 7, 2026
Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialJoseph P Broderick, Andrew M Naidech, Jordan J Elm, et al.
Lancet (London, England)|March 1, 2025
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trialRoland Veltkamp, Eleni Korompoki, Kirsten H Harvey, et al.
European Journal of Neurology|February 11, 2023
Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopeniaKatarzyna Krzywicka, Diana Aguiar de Sousa, Charlotte Cordonnier, et al.
The Lancet. Neurology|February 22, 2025
Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort studyAnita van de Munckhof, Mayte Sánchez van Kammen, Turgut Tatlisumak, et al.
The New England Journal of Medicine|May 24, 2023
Early versus Later Anticoagulation for Stroke with Atrial FibrillationUrs Fischer, Masatoshi Koga, Daniel Strbian, et al.
Pageof 22

Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Neurological Research and Practice|June 26, 2025
Baseline characteristics of patients with acute ischaemic stroke included in the randomised controlled Find-AF 2 trialKatrin Wasser, Tobias Uhe, Wolf-Rüdiger Schäbitz, et al.
European Stroke Journal|April 4, 2024
Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19Adrian Scutelnic, Anita van de Munckhof, Angel T Miraclin, et al.
European Stroke Journal|September 29, 2023
Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopeniaJohannes Weller, Katarzyna Krzywicka, Anita van de Munckhof, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 18, 2024
Reducing the global burden of cerebral venous thrombosis: An international research agendaJonathan M Coutinho, Anita van de Munckhof, Diana Aguiar de Sousa, et al.
Science Translational Medicine|January 14, 2026
Brain-derived tau for monitoring brain injury in acute ischemic strokeNaomi Vlegels, Nicoló L Knuth, Konstantin A Steiner, et al.
Lancet (London, England)|February 7, 2026
Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialJoseph P Broderick, Andrew M Naidech, Jordan J Elm, et al.
Lancet (London, England)|March 1, 2025
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trialRoland Veltkamp, Eleni Korompoki, Kirsten H Harvey, et al.
European Journal of Neurology|February 11, 2023
Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopeniaKatarzyna Krzywicka, Diana Aguiar de Sousa, Charlotte Cordonnier, et al.
The Lancet. Neurology|February 22, 2025
Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort studyAnita van de Munckhof, Mayte Sánchez van Kammen, Turgut Tatlisumak, et al.
The New England Journal of Medicine|May 24, 2023
Early versus Later Anticoagulation for Stroke with Atrial FibrillationUrs Fischer, Masatoshi Koga, Daniel Strbian, et al.
Pageof 22